Cargando…
Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]
Autores principales: | da Silva, Vinicius Trindade Gomes, Gebrin, Thiago, Paiva, Wellingson Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620836/ https://www.ncbi.nlm.nih.gov/pubmed/36325433 http://dx.doi.org/10.2147/NDT.S392309 |
Ejemplares similares
-
Spheno-orbital meningiomas: Is orbit reconstruction mandatory? Long-term outcomes and exophthalmos improvement
por: dos Santos, Alexandra Gomes, et al.
Publicado: (2022) -
Elevated Serum Complement C1q Levels After Traumatic Brain Injury [Letter]
por: Paiva, Wellingson Silva, et al.
Publicado: (2022) -
Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area [Letter]
por: Teixeira, Theo Moraes, et al.
Publicado: (2023) -
Virtual reality for the treatment of posttraumatic disorders
por: Moraes, Thiago Mazzoli, et al.
Publicado: (2016) -
Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study
por: Bai, Xuexue, et al.
Publicado: (2022)